Aller au contenu principal
Profil bibliographique

Yazan Omari

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
1Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and OutcomesColorectal Cancer Surgical TreatmentsColorectal Cancer Screening and DetectionAcute Myocardial Infarction Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Stage IV Rectal Adenocarcinoma After Negative Multitarget Stool DNA-Fecal Immunochemical Test in a Symptomatic Patient: Misapplication of a Screening Test in a Diagnostic Context

Yazan Omari, Brian Nohomovich, Dima Sallam, Serge Sorser

Multitarget stool DNA-fecal immunochemical testing (mt-sDNA-FIT) is validated for colorectal cancer (CRC) screening in asymptomatic, average-risk adults. However, its application in symptomatic patients represents a misuse of a screening tool in a diagnostic context and does not meet diagnostic standards as defined …

us (code pays fourni par la source)

0 citations Cureus
2025 conference-abstract OpenAlex

S4106 Missed by Non-Invasive Screening: A Case of Obstructing Rectal Adenocarcinoma Highlighting the Critical Role of Colonoscopy in Early Detection

Yazan Omari, Brian Nohomovich, Dima Sallam, Ahmad Alomari et autres

Introduction: Rectal cancer is a significant cause of gastrointestinal morbidity, often presenting with nonspecific symptoms that can delay diagnosis. This case report highlights the diagnostic challenges and management of a 77-year-old man with alternating diarrhea and constipation, whose malignancy was not detected …

0 citations The American Journal of Gastroenterology
Accès ouvert 2022 article OpenAlex

Chronic amiodarone therapy and mortality among atrial fibrillation patients; insights from a real-life contemporary population

Gal Tsaban, Michal Markovich Gordon, Yazan Omari, Louise Kezerle et autres

Abstract Background Although associated with potentially serious side effects, amiodarone is the most effective pharmacotherapy to achieve rhythm control among patients with atrial fibrillation (AF). Recent clinical trials advocate early rhythm control in AF. The effect of amiodarone treatment on mortality among …

il (code pays fourni par la source)

0 citations European Heart Journal
Accès ouvert 2022 article OpenAlex

Amiodarone and lung toxicity in a real-life contemporary population

Gal Tsaban, Michal Markovich Gordon, Yazan Omari, Louise Kezerle et autres

Abstract Background Amiodarone-induced lung toxicity (ALT) is severe and potentially fatal. Most data on ALT are derived from previous decades when amiodarone was administrated chronically in higher doses, while currently, low-dose amiodarone 200 mg is routinely used. Whether low-dose amiodarone treatment is …

il (code pays fourni par la source)

1 citation European Heart Journal
Accès ouvert 2022 article OpenAlex

Amiodarone therapy and risk of primary lung cancer; insights from a real-life contemporary population study

Gal Tsaban, Michal Markovich Gordon, Yazan Omari, Louise Kezerle et autres

Abstract Background Amiodarone is the most effective antiarrhythmic therapy to maintain sinus rhythm in atrial fibrillation (AF) patients. There is a controversy regarding the association of amiodarone therapy with an increased risk of lung cancer. We aimed to assess the relationship between …

il (code pays fourni par la source)

0 citations European Heart Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.